# Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

> **NCT05591118** · PHASE3 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 500 (estimated)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Anticoagulant Therapy
- **DEVICE:** Catheter-Directed Therapy

## Key facts

- **NCT ID:** NCT05591118
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-17
- **Primary completion:** 2027-03-29
- **Final completion:** 2027-08-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05591118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05591118, "Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05591118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*